FDA rejects Cytokinetics heart disease trial drug
Cytokinetics, a US-based biopharmaceutical company, announced the FDA had rejected its new drug application for approving a trial drug to treat heart problems.
Drugs
Pharma
Drugs
Pharma
Eiasi files market authorization for Alzheimer’s drug in Japan
Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.
Drugs
Medical
Pharma
China’s Everest starts first phase operations to make mRNA vaccines
Everest Medicines, a Chinese biopharmaceutical company, announced the start of operations in the first phase at a global manufacturing site to make an.
Drugs
Pharma
Merck acquires Imago BioSciences for $1.35 billion
Merck, a US multinational pharmaceutical company, announced it would acquire Imago BioSciences for $1.35 billion.